XERS News & Analysis
3 articles
Market Mood
Xeris Biopharma COO Kevin McCulloch Sells $127,308 in Stock
Kevin McCulloch, COO of Xeris Biopharma (XERS), sold $127,308 worth of stock. The transaction involved 30,000 shares at a price of approximately $4.24 per share. This sale is part of normal stock trading activities. Such insider selling may raise questions among investors about the company’s future prospects. Monitoring insider actions can provide signals for ordinary investors regarding the company's health.
Read More: Xeris Biopharma COO Kevin McCulloch Sells $127,308 in Stock
Xeris Biopharma (XERS) Beth Hecht Sells $141,434 in Stock
Beth Hecht of Xeris Biopharma (XERS) sold $141,434 worth of company stock. This sale may indicate her views on the company's current valuation or future outlook. Such insider transactions can be significant for investors as they may reflect insider sentiment regarding share performance. Understanding these trades is important for estimating market trends and potential investment decisions.
Read More: Xeris Biopharma (XERS) Beth Hecht Sells $141,434 in Stock
Xeris Biopharma (XERS) CFO Steven Pieper Sells $42,500 in Shares
Steven Pieper, CFO of Xeris Biopharma (XERS), sold $42,500 worth of shares. This sale is notable as it may indicate the CFO's personal financial decisions, but does not inherently reflect the company's performance or outlook. Insider selling can sometimes raise questions among investors regarding a company's future. Understanding such transactions could inform investor sentiment and market behavior.
Read More: Xeris Biopharma (XERS) CFO Steven Pieper Sells $42,500 in Shares